LENZ

LENZ Therapeutics Q4 FY 2025 Financial Update

LENZ Therapeutics Q4 FY 2025 Financial Update

Company Overview LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44% for the…

LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected

LENZ Therapeutics, Inc.

Categories